236 related articles for article (PubMed ID: 8683940)
21. Cooperative interactions of laminin 5 gamma2 chain, matrix metalloproteinase-2, and membrane type-1-matrix/metalloproteinase are required for mimicry of embryonic vasculogenesis by aggressive melanoma.
Seftor RE; Seftor EA; Koshikawa N; Meltzer PS; Gardner LM; Bilban M; Stetler-Stevenson WG; Quaranta V; Hendrix MJ
Cancer Res; 2001 Sep; 61(17):6322-7. PubMed ID: 11522618
[TBL] [Abstract][Full Text] [Related]
22. Expression of integrin alpha5beta1 and MMPs associated with epithelioid morphology and malignancy of uveal melanoma.
Béliveau A; Bérubé M; Rousseau A; Pelletier G; Guérin SL
Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2363-72. PubMed ID: 10892885
[TBL] [Abstract][Full Text] [Related]
23. MMP-2 expression in uveal melanoma: differential activation status dictated by the cellular environment.
Bérubé M; Deschambeault A; Boucher M; Germain L; Petitclerc E; Guérin SL
Mol Vis; 2005 Dec; 11():1101-11. PubMed ID: 16379022
[TBL] [Abstract][Full Text] [Related]
24. Uveal melanoma cell staining for CD34 and assessment of tumor vascularity.
Chen X; Maniotis AJ; Majumdar D; Pe'er J; Folberg R
Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2533-9. PubMed ID: 12147581
[TBL] [Abstract][Full Text] [Related]
25. Tumor, node, metastasis classification of malignant ciliary body and choroidal melanoma evaluation of the 6th edition and future directions.
Kujala E; Kivelä T
Ophthalmology; 2005 Jun; 112(6):1135-44. PubMed ID: 15885792
[TBL] [Abstract][Full Text] [Related]
26. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
Kvanta A; Steen B; Seregard S
Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
[TBL] [Abstract][Full Text] [Related]
27. Proteomic analysis of uveal melanoma reveals novel potential markers involved in tumor progression.
Zuidervaart W; Hensbergen PJ; Wong MC; Deelder AM; Tensen CP; Jager MJ; Gruis NA
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):786-93. PubMed ID: 16505008
[TBL] [Abstract][Full Text] [Related]
28. Comparison of microcirculation patterns and MIB-1 immunoreactivity in iris and posterior uveal melanoma.
Chowers I; Folberg R; Livni N; Pe'er J
Ophthalmology; 2001 Feb; 108(2):367-71. PubMed ID: 11158814
[TBL] [Abstract][Full Text] [Related]
29. Cripto-1 expression in uveal melanoma: an immunohistochemical study.
Mallikarjuna K; Vaijayanthi P; Krishnakumar S
Exp Eye Res; 2007 Jun; 84(6):1060-6. PubMed ID: 17412323
[TBL] [Abstract][Full Text] [Related]
30. Matrix metalloproteinase-2 (MMP-2) immunoreactive protein--a new prognostic marker in uveal melanoma?
Väisänen A; Kallioinen M; von Dickhoff K; Laatikainen L; Höyhtyä M; Turpeenniemi-Hujanen T
J Pathol; 1999 May; 188(1):56-62. PubMed ID: 10398141
[TBL] [Abstract][Full Text] [Related]
31. Detection of melanoma cells in the blood of melanoma patients by melanoma-inhibitory activity (MIA) reverse transcription-PCR.
Mühlbauer M; Langenbach N; Stolz W; Hein R; Landthaler M; Buettner R; Bosserhoff AK
Clin Cancer Res; 1999 May; 5(5):1099-105. PubMed ID: 10353744
[TBL] [Abstract][Full Text] [Related]
32. Regulation of uveal melanoma interconverted phenotype by hepatocyte growth factor/scatter factor (HGF/SF).
Hendrix MJ; Seftor EA; Seftor RE; Kirschmann DA; Gardner LM; Boldt HC; Meyer M; Pe'er J; Folberg R
Am J Pathol; 1998 Apr; 152(4):855-63. PubMed ID: 9546344
[TBL] [Abstract][Full Text] [Related]
33. Increased p21-activated kinase-1 expression is associated with invasive potential in uveal melanoma.
Pavey S; Zuidervaart W; van Nieuwpoort F; Packer L; Jager M; Gruis N; Hayward N
Melanoma Res; 2006 Aug; 16(4):285-96. PubMed ID: 16845324
[TBL] [Abstract][Full Text] [Related]
34. Bilateral uveal melanoma presenting simultaneously.
Omulecki W; Damato BE; Sekundo W; Lee WR; Toczyska-Rozentryt E; Omulecka A
Ger J Ophthalmol; 1994 Aug; 3(4-5):228-31. PubMed ID: 7804108
[TBL] [Abstract][Full Text] [Related]
35. Bone morphogenetic protein 7 inhibits tumor growth of human uveal melanoma in vivo.
Notting I; Buijs J; Mintardjo R; van der Horst G; Vukicevic S; Lowik C; Schalij-Delfos N; Keunen J; van der Pluijm G
Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):4882-9. PubMed ID: 17962434
[TBL] [Abstract][Full Text] [Related]
36. The spatial distribution of monosomy 3 and network vasculogenic mimicry patterns in uveal melanoma.
Meir T; Zeschnigk M; Masshöfer L; Pe'er J; Chowers I
Invest Ophthalmol Vis Sci; 2007 May; 48(5):1918-22. PubMed ID: 17460242
[TBL] [Abstract][Full Text] [Related]
37. [Correlation of tumor angiogenesis with clinicopathologic prognostic parameters in choroidal melanoma].
Wang FH; Li B; Sun XL; Li LQ; Chen CX
Zhonghua Yan Ke Za Zhi; 2003 Feb; 39(2):68-72. PubMed ID: 12783682
[TBL] [Abstract][Full Text] [Related]
38. Uveal melanoma: no expression of HLA-G.
Hurks HM; Valter MM; Wilson L; Hilgert I; van den Elsen PJ; Jager MJ
Invest Ophthalmol Vis Sci; 2001 Dec; 42(13):3081-4. PubMed ID: 11726606
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinases in human melanoma cell lines and xenografts: increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression.
Hofmann UB; Westphal JR; Waas ET; Zendman AJ; Cornelissen IM; Ruiter DJ; van Muijen GN
Br J Cancer; 1999 Nov; 81(5):774-82. PubMed ID: 10555745
[TBL] [Abstract][Full Text] [Related]
40. Lack of lymphangiogenesis despite coexpression of VEGF-C and its receptor Flt-4 in uveal melanoma.
Clarijs R; Schalkwijk L; Ruiter DJ; de Waal RM
Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1422-8. PubMed ID: 11381041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
